6,009 Intuitive Surgical, Inc. $ISRG Shares Purchased by Focus Advisor Solutions LLC

Focus Advisor Solutions LLC boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 166.1% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 9,626 shares of the medical equipment provider’s stock after buying an additional 6,009 shares during the period. Focus Advisor Solutions LLC’s holdings in Intuitive Surgical were worth $3,915,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently bought and sold shares of the company. Bank of New York Mellon Corp acquired a new stake in Intuitive Surgical in the second quarter valued at about $1,335,753,000. Arrowstreet Capital Limited Partnership boosted its holdings in Intuitive Surgical by 95.3% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after purchasing an additional 1,027,475 shares in the last quarter. Assenagon Asset Management S.A. boosted its holdings in Intuitive Surgical by 55.8% in the 3rd quarter. Assenagon Asset Management S.A. now owns 1,557,940 shares of the medical equipment provider’s stock valued at $633,505,000 after purchasing an additional 558,099 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new position in Intuitive Surgical during the 3rd quarter worth approximately $136,743,000. Finally, Voya Investment Management LLC increased its position in Intuitive Surgical by 97.2% during the 3rd quarter. Voya Investment Management LLC now owns 491,914 shares of the medical equipment provider’s stock worth $200,028,000 after purchasing an additional 242,468 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Craig H. Barratt sold 1,150 shares of Intuitive Surgical stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $460.00, for a total value of $529,000.00. Following the transaction, the director owned 1,150 shares in the company, valued at $529,000. This trade represents a 50.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $458.15, for a total transaction of $183,260.00. Following the sale, the executive vice president directly owned 6,236 shares of the company’s stock, valued at $2,857,023.40. This represents a 6.03% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 39,363 shares of company stock valued at $17,738,749 in the last quarter. Insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on ISRG shares. KeyCorp reissued an “overweight” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. BNP Paribas Exane raised Intuitive Surgical to an “outperform” rating in a report on Tuesday, July 28th. TD Cowen reiterated a “buy” rating and issued a $485.00 price objective on shares of Intuitive Surgical in a research report on Monday, October 19th. Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Thursday, October 22nd. Finally, Wells Fargo & Company reissued an “overweight” rating and issued a $486.00 target price (down from $487.00) on shares of Intuitive Surgical in a report on Wednesday, October 21st. One analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $495.90.

View Our Latest Analysis on Intuitive Surgical

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $399.06 on Friday. The business’s fifty day moving average price is $423.51 and its two-hundred day moving average price is $427.91. The stock has a market cap of $138.33 billion, a PE ratio of 49.08, a price-to-earnings-growth ratio of 3.02 and a beta of 1.45. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. The business had revenue of $3.05 billion during the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company’s revenue was up 21.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.40 earnings per share. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Key Intuitive Surgical News

These are some of the ISRG news items that stood out recently:

  • Positive Sentiment: A BTIG Research analyst reportedly expects ISRG shares to rise, providing a positive analyst signal; the headline does not specify a price target or the reasoning. BTIG analyst article
  • Positive Sentiment: Industry coverage casts Intuitive Surgical as a leading beneficiary of expanding surgical-robotics adoption, citing growth in robotic procedures and use of its da Vinci system. A separate medical-device roundup also identifies ISRG as a stock to watch, though neither story reports a new company announcement. Surgical robotics industry article Medical-device stocks article
  • Neutral Sentiment: An executive sold 46 shares under a pre-arranged Rule 10b5-1 plan. The transaction was small and scheduled in advance, so it is a limited signal about management’s outlook. Insider-sale report

About Intuitive Surgical

(Free Report)

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.

Read More

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.